Phibro Animal Health (PAHC) Stock Forecast, Price Target & Predictions
PAHC Stock Forecast
Phibro Animal Health stock forecast is as follows: an average price target of $18.67 (represents a -20.18% downside from PAHC’s last price of $23.39) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
PAHC Price Target
The average price target for Phibro Animal Health (PAHC) is $18.67 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $21.00 to $17.00. This represents a potential -20.18% downside from PAHC's last price of $23.39.
PAHC Analyst Ratings
According to 3 Wall Street analysts, Phibro Animal Health's rating consensus is 'Buy'. The analyst rating breakdown for PAHC stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 1 'Hold' (33.33%), 1 'Sell' (33.33%), and 0 'Strong Sell' (0.00%).
Phibro Animal Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 21, 2022 | - | Roth Capital | $18.00 | $12.75 | 41.18% | -23.04% |
| Sep 16, 2022 | - | Barclays | $17.00 | $14.29 | 18.96% | -27.32% |
| Aug 26, 2022 | - | Morgan Stanley | $21.00 | $16.06 | 30.76% | -10.22% |
The latest Phibro Animal Health stock forecast, released on Dec 21, 2022 by Roth Capital company, set a price target of $18.00, which represents a 41.18% increase from the stock price at the time of the forecast ($12.75), and a -23.04% decrease from PAHC last price ($23.39).
Phibro Animal Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $23.39 | $23.39 | $23.39 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Phibro Animal Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Phibro Animal Health's last price of $23.39. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 10, 2024 | Barclays | Underweight | Underweight | Hold |
| Dec 21, 2022 | Roth Capital | - | Buy | Initialise |
| Sep 16, 2022 | Barclays | Underweight | Underweight | Hold |
| Aug 26, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Phibro Animal Health's last stock rating was published by Barclays on May 10, 2024. The company gave PAHC a "Underweight" rating, the same as its previous rate.
Phibro Animal Health Financial Forecast
Phibro Animal Health Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $249.94M | $231.30M | $255.05M | $245.70M | $244.65M | $232.52M | $255.30M | $239.62M | $232.71M | $214.66M | $220.28M | $211.73M | $206.15M | $195.19M | $185.88M | $210.74M | $214.01M | $189.72M | $203.88M | $205.74M |
| Avg Forecast | $289.62M | $285.26M | $280.96M | $276.73M | $316.52M | $309.50M | $292.26M | $246.70M | $260.49M | $253.65M | $240.93M | $242.00M | $256.13M | $246.69M | $241.29M | $232.09M | $250.04M | $230.53M | $215.28M | $201.06M | $214.28M | $208.06M | $205.48M | $189.08M | $191.20M | $207.45M | $218.87M | $199.38M | $206.00M | $214.94M |
| High Forecast | $334.21M | $329.18M | $324.22M | $319.34M | $365.25M | $374.31M | $350.81M | $284.68M | $300.59M | $253.65M | $247.14M | $279.26M | $295.56M | $284.67M | $278.43M | $232.09M | $250.04M | $230.53M | $215.28M | $201.06M | $214.28M | $208.06M | $205.48M | $189.08M | $191.20M | $207.45M | $218.87M | $199.38M | $206.00M | $214.94M |
| Low Forecast | $259.03M | $255.13M | $251.29M | $247.50M | $283.09M | $273.85M | $262.52M | $220.64M | $232.97M | $253.65M | $237.18M | $216.44M | $229.08M | $220.64M | $215.80M | $232.09M | $250.04M | $230.53M | $215.28M | $201.06M | $214.28M | $208.06M | $205.48M | $189.08M | $191.20M | $207.45M | $218.87M | $199.38M | $206.00M | $214.94M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.04% | 0.96% | 1.00% | 1.00% | 1.01% | 1.00% | 1.02% | 1.04% | 1.08% | 1.07% | 1.03% | 1.02% | 1.00% | 1.03% | 0.97% | 1.02% | 0.98% | 0.95% | 0.99% | 0.96% |
Phibro Animal Health's average Quarter revenue forecast for Mar 24 based on 1 analysts is $253.65M, with a low forecast of $253.65M, and a high forecast of $253.65M. PAHC's average Quarter revenue forecast represents a 1.48% increase compared to the company's last Quarter revenue of $249.94M (Dec 23).
Phibro Animal Health EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $15.70M | $-700.00K | $33.08M | $18.60M | $24.91M | $22.61M | $22.90M | $27.68M | $34.49M | $20.37M | $27.00M | $28.78M | $27.40M | $27.43M | $26.84M | $30.57M | $28.98M | $15.19M | $19.92M | $29.81M |
| Avg Forecast | $33.51M | $33.00M | $32.51M | $32.02M | $36.62M | $35.81M | $33.81M | $28.54M | $30.14M | $48.92M | $27.87M | $28.00M | $29.63M | $44.47M | $40.93M | $21.72M | $23.40M | $40.43M | $20.15M | $18.82M | $20.06M | $28.78M | $19.23M | $17.70M | $17.90M | $26.98M | $20.49M | $18.66M | $19.28M | $32.58M |
| High Forecast | $38.67M | $38.08M | $37.51M | $36.95M | $42.26M | $43.31M | $40.59M | $32.94M | $34.78M | $58.70M | $28.59M | $32.31M | $34.19M | $53.37M | $49.11M | $21.72M | $23.40M | $48.51M | $20.15M | $18.82M | $20.06M | $34.54M | $19.23M | $17.70M | $17.90M | $32.37M | $20.49M | $18.66M | $19.28M | $39.10M |
| Low Forecast | $29.97M | $29.52M | $29.07M | $28.63M | $32.75M | $31.68M | $30.37M | $25.53M | $26.95M | $39.13M | $27.44M | $25.04M | $26.50M | $35.58M | $32.74M | $21.72M | $23.40M | $32.34M | $20.15M | $18.82M | $20.06M | $23.02M | $19.23M | $17.70M | $17.90M | $21.58M | $20.49M | $18.66M | $19.28M | $26.07M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.56% | -0.03% | 1.12% | 0.42% | 0.61% | 1.04% | 0.98% | 0.68% | 1.71% | 1.08% | 1.35% | 1.00% | 1.42% | 1.55% | 1.50% | 1.13% | 1.41% | 0.81% | 1.03% | 0.91% |
1 analysts predict PAHC's average Quarter EBITDA for Mar 24 to be $48.92M, with a high of $58.70M and a low of $39.13M. This is 211.56% upper than Phibro Animal Health's previous annual EBITDA (Dec 23) of $15.70M.
Phibro Animal Health Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $1.27M | $-8.00M | $11.50M | $10.00M | $7.21M | $3.86M | $7.50M | $17.69M | $17.46M | $6.53M | $17.12M | $12.16M | $12.80M | $12.30M | $5.64M | $13.50M | $11.89M | $2.52M | $8.80M | $14.85M |
| Avg Forecast | $23.13M | $22.32M | $21.31M | $14.00M | $18.26M | $17.35M | $17.25M | $10.06M | $13.53M | $22.63M | $11.36M | $9.33M | $15.12M | $20.57M | $16.88M | $10.69M | $15.29M | $18.70M | $13.30M | $11.91M | $12.69M | $12.16M | $11.37M | $8.18M | $9.34M | $11.91M | $11.61M | $9.83M | $14.70M | $16.23M |
| High Forecast | $27.76M | $26.79M | $25.57M | $16.80M | $21.92M | $21.58M | $19.25M | $12.08M | $13.53M | $27.15M | $13.47M | $11.36M | $18.14M | $24.68M | $20.26M | $10.69M | $15.29M | $22.44M | $13.30M | $11.91M | $12.69M | $14.59M | $11.37M | $8.18M | $9.34M | $14.30M | $11.61M | $9.83M | $14.70M | $19.48M |
| Low Forecast | $19.96M | $19.26M | $18.38M | $12.08M | $15.75M | $14.39M | $13.64M | $8.68M | $13.52M | $18.10M | $10.10M | $8.12M | $13.04M | $16.46M | $13.51M | $10.69M | $15.29M | $14.96M | $13.30M | $11.91M | $12.69M | $9.73M | $11.37M | $8.18M | $9.34M | $9.53M | $11.61M | $9.83M | $14.70M | $12.98M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.11% | -0.86% | 0.76% | 0.49% | 0.43% | 0.36% | 0.49% | 0.95% | 1.31% | 0.55% | 1.35% | 1.00% | 1.13% | 1.50% | 0.60% | 1.13% | 1.02% | 0.26% | 0.60% | 0.91% |
Phibro Animal Health's average Quarter net income forecast for Mar 24 is $22.63M, with a range of $18.10M to $27.15M. PAHC's average Quarter net income forecast represents a 1676.04% increase compared to the company's last Quarter net income of $1.27M (Dec 23).
Phibro Animal Health SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $62.91M | $68.50M | $52.90M | $57.00M | $61.54M | $54.96M | $55.50M | $52.43M | $48.38M | $50.07M | $50.67M | $49.03M | $48.38M | $48.43M | $42.45M | $48.23M | $49.49M | $47.52M | $53.20M | $42.30M |
| Avg Forecast | $65.91M | $64.92M | $63.94M | $62.98M | $72.03M | $70.44M | $66.51M | $56.14M | $59.28M | $67.07M | $54.83M | $55.07M | $58.29M | $60.97M | $46.77M | $52.82M | $56.90M | $55.43M | $48.99M | $45.76M | $48.76M | $49.03M | $46.76M | $43.03M | $43.51M | $42.56M | $49.81M | $45.37M | $46.88M | $46.24M |
| High Forecast | $76.06M | $74.91M | $73.78M | $72.67M | $83.12M | $85.18M | $79.84M | $64.79M | $68.41M | $80.48M | $56.24M | $63.55M | $67.26M | $73.17M | $56.12M | $52.82M | $56.90M | $66.51M | $48.99M | $45.76M | $48.76M | $58.84M | $46.76M | $43.03M | $43.51M | $51.07M | $49.81M | $45.37M | $46.88M | $55.49M |
| Low Forecast | $58.95M | $58.06M | $57.19M | $56.33M | $64.42M | $62.32M | $59.74M | $50.21M | $53.02M | $53.65M | $53.98M | $49.26M | $52.13M | $48.78M | $37.41M | $52.82M | $56.90M | $44.34M | $48.99M | $45.76M | $48.76M | $39.23M | $46.76M | $43.03M | $43.51M | $34.05M | $49.81M | $45.37M | $46.88M | $36.99M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.15% | 1.24% | 0.91% | 0.93% | 1.32% | 1.04% | 0.98% | 0.95% | 0.99% | 1.09% | 1.04% | 1.00% | 1.03% | 1.13% | 0.98% | 1.13% | 0.99% | 1.05% | 1.13% | 0.91% |
Phibro Animal Health's average Quarter SG&A projection for Mar 24 is $67.07M, based on 1 Wall Street analysts, with a range of $53.65M to $80.48M. The forecast indicates a 6.60% rise compared to PAHC last annual SG&A of $62.91M (Dec 23).
Phibro Animal Health EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | $0.03 | $-0.20 | - | $0.25 | $0.18 | $0.10 | $0.18 | $0.44 | $0.43 | $0.16 | $0.42 | $0.30 | $0.32 | $0.30 | $0.14 | $0.33 | $0.29 | $0.06 | $0.22 | $0.37 |
| Avg Forecast | $0.57 | $0.55 | $0.53 | $0.34 | $0.45 | $0.43 | $0.42 | $0.25 | $0.33 | $0.29 | $0.28 | $0.23 | $0.37 | $0.34 | $0.30 | $0.26 | $0.38 | $0.35 | $0.33 | $0.29 | $0.31 | $0.35 | $0.28 | $0.20 | $0.23 | $0.34 | $0.29 | $0.24 | $0.36 | $0.43 |
| High Forecast | $0.68 | $0.66 | $0.63 | $0.41 | $0.54 | $0.53 | $0.47 | $0.30 | $0.33 | $0.35 | $0.33 | $0.28 | $0.45 | $0.40 | $0.36 | $0.26 | $0.38 | $0.35 | $0.33 | $0.29 | $0.31 | $0.35 | $0.28 | $0.20 | $0.23 | $0.34 | $0.29 | $0.24 | $0.36 | $0.43 |
| Low Forecast | $0.49 | $0.47 | $0.45 | $0.30 | $0.39 | $0.35 | $0.34 | $0.21 | $0.33 | $0.25 | $0.25 | $0.20 | $0.32 | $0.29 | $0.26 | $0.26 | $0.38 | $0.35 | $0.33 | $0.29 | $0.31 | $0.35 | $0.28 | $0.20 | $0.23 | $0.34 | $0.29 | $0.24 | $0.36 | $0.43 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.11% | -0.87% | - | 0.75% | 0.60% | 0.38% | 0.48% | 1.25% | 1.31% | 0.55% | 1.34% | 0.86% | 1.14% | 1.49% | 0.61% | 0.97% | 1.01% | 0.25% | 0.61% | 0.86% |
According to 1 Wall Street analysts, Phibro Animal Health's projected average Quarter EPS for Mar 24 is $0.29, with a low estimate of $0.25 and a high estimate of $0.35. This represents a 820.63% increase compared to PAHC previous annual EPS of $0.03 (Dec 23).
Phibro Animal Health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PROC | Procaps Group | $0.57 | $10.00 | 1654.39% | - |
| PCRX | Pacira BioSciences | $17.03 | $35.00 | 105.52% | Hold |
| ANIP | ANI Pharmaceuticals | $55.10 | $79.00 | 43.38% | Buy |
| COLL | Collegium Pharmaceutical | $30.00 | $40.50 | 35.00% | Buy |
| PBH | Prestige Consumer Healthcare | $82.67 | $89.50 | 8.26% | Buy |
| DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
| PAHC | Phibro Animal Health | $23.39 | $18.67 | -20.18% | Buy |